Done Deal: Organon Completes Acquisition of Dermavant
Organon has completed the acquisition of Dermavant Sciences Ltd. from Roivant including tapinarof cream, 1% (Vtama, Dermavant). Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, is approved by the U.S. Food and Drug Administration (FDA) for treatment of mild, moderate, and severe plaque psoriasis in adults. The FDA is reviewing a supplemental New Drug Application […]